Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis

NCT00409175 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Familial Amyloid Polyneuropathy

Interventions

DRUG: Fx-1006A
DRUG: Placebo

Sponsor

Pfizer